Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Can AlphaFold's breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?
McMaster B. et al, (2024), Nature methods
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs.
Weeratunga P. et al, (2023), Nature communications, 14
Can we predict T cell specificity with digital biology and machine learning?
Hudson D. et al, (2023), Nature Reviews Immunology, 23, 511 - 521
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
Jackson C. et al, (2023), The Lancet Respiratory Medicine, 11, 673 - 684
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
Zheng B. et al, (2023), The Lancet Regional Health - Europe, 29, 100635 - 100635
Group A Streptococcus induces CD1a-autoreactive T cells and promotes psoriatic inflammation.
Chen Y-L. et al, (2023), Science immunology, 8
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination
Yin Z. et al, (2023), Cell Reports, 42, 112470 - 112470
Antibody and memory B cell responses to the dengue virus NS1 antigen in individuals with varying severity of past infection.
Ramu ST. et al, (2023), Immunology
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types.
Bosma AL. et al, (2023), JAAD international, 10, 14 - 24
Differentiating dengue from other febrile illnesses: a dilemma faced by clinicians in dengue endemic countries.
Malavige GN. et al, (2023), The Lancet. Global health, 11, e306 - e307
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
McAuley HJC. et al, (2023), eClinicalMedicine, 57, 101896 - 101896
Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury
Cross AR. et al, (2023), JCI Insight, 8
Facing the escalating burden of dengue: Challenges and perspectives.
Malavige GN. et al, (2023), PLOS Glob Public Health, 3
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402
Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma.
Ma R. et al, (2022), Neuro-oncology, 24, 2093 - 2106
Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.
Jeewandara C. et al, (2022), Immunology, 167, 263 - 274
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716